$127 B

MDT Mkt cap, 15-Oct-2018

$7.4 B

Medtronic Revenue Q1, 2019
Medtronic Gross profit (Q1, 2019)5.2 B
Medtronic Gross profit margin (Q1, 2019), %70.2%
Medtronic Net income (Q1, 2019)1.1 B
Medtronic EBIT (Q1, 2019)1.2 B
Medtronic Cash, 27-Jul-20184.4 B
Medtronic EV146.2 B

Medtronic Revenue

Medtronic revenue was $29.95 b in FY, 2018 which is a 0.8% year over year increase from the previous period.

Embed Graph

Medtronic Revenue Breakdown

Embed Graph

Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

Medtronic Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

17.0b20.3b28.8b29.7b30.0b

Revenue growth, %

19%42%3%1%

Cost of goods sold

4.3b6.3b9.1b9.3b9.1b

Gross profit

12.7b14.0b19.7b20.4b20.9b

Gross profit Margin, %

75%69%68%69%70%

R&D expense

2.2b2.2b2.3b

General and administrative expense

9.5b9.7b10.0b

Operating expense total

11.7b11.9b2.3b

Depreciation and amortization

1.9b2.0b1.8b

EBIT

3.8b5.3b5.3b6.7b

EBIT margin, %

19%18%18%22%

Interest expense

108.0m666.0m1.4b1.1b1.1b

Interest income

386.0m431.0m366.0m397.0m

Pre tax profit

4.3b4.6b5.7b

Income tax expense

640.0m811.0m798.0m578.0m2.6b

Net Income

3.1b2.7b3.5b4.0b3.1b

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

7.3b7.1b6.9b7.2b7.3b7.3b7.4b7.1b21.8b7.4b

Cost of goods sold

2.5b2.2b2.1b2.3b2.3b2.3b2.3b2.1b6.7b2.2b

Gross profit

4.8b4.9b4.8b4.9b5.0b5.0b5.0b4.9b15.1b5.2b

Gross profit Margin, %

66%69%69%68%68%69%68%70%69%70%

R&D expense

1.7b585.0m

Operating expense total

37.1m1.7b585.0m

Depreciation and amortization

446.0m

EBIT

1.1b1.3b1.4b1.2b1.4b1.2b1.4b1.9b4.7b1.2b

EBIT margin, %

16%18%20%16%19%16%19%27%22%17%

Interest expense

306.0m324.0m275.0m272.0m264.0m268.0m286.0m273.0m829.0m242.0m

Interest income

115.0m107.0m99.0m93.0m91.0m88.0m92.0m100.0m290.0m

Pre tax profit

(37.1m)1.2b1.7b4.0b1.2b

Income tax expense

120.0m563.0m84.0m59.0m101.0m147.0m186.0m(285.0m)2.3b103.0m

Net Income

(37.1m)820.0m520.0m1.1b929.0m1.1b820.0m1.0b2.0b1.6b1.1b

Medtronic Balance Sheet

Annual

USDY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

13.2m4.8b186.4m5.0b3.7b

Accounts Receivable

17.1m5.6b6.0b

Inventories

1.7b3.5b3.5b3.3b3.6b

Current Assets

21.2b30.8b23.6b24.9b23.0b

PP&E

2.4b4.7b4.8b4.4b4.6b

Goodwill

10.6b40.5b41.5b38.5b39.5b

Total Assets

37.9b106.7b99.8b99.8b91.4b

Accounts Payable

742.0m1.6b1.7b1.7b1.6b

Short-term debt

1.6b2.4b993.0m7.5b2.1b

Current Liabilities

5.6b9.2b7.2b14.2b10.1b

Long-term debt

10.3b33.8b30.2b25.9b23.7b

Total Debt

11.9b36.2b31.2b25.9b23.7b

Total Liabilities

49.4b40.6b

Additional Paid-in Capital

29.6b28.1b

Retained Earnings

19.9b54.4b53.9b23.4b24.4b

Total Equity

19.4b53.2b52.1b50.4b50.8b

Debt to Equity Ratio

0.6 x0.7 x0.6 x0.5 x0.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x0.3 x0.3 x

Financial Leverage

2 x2 x1.9 x2 x1.8 x

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

46.0k3.0b2.4b2.7b3.1b3.0b2.8b4.7b5.5b6.4b4.4b

Accounts Receivable

(68.0m)

Inventories

3.4b3.5b3.5b3.6b3.7b3.7b3.5b3.8b3.7b

Current Assets

46.0k29.1b28.7b27.6b23.5b22.5b22.4b24.8b25.2b26.6b22.5b

PP&E

4.7b4.7b4.6b4.8b4.9b4.9b4.4b4.4b4.5b4.5b

Goodwill

40.7b41.3b40.4b41.3b41.7b41.2b39.2b39.1b39.8b39.0b

Total Assets

46.0k105.0b105.0b103.0b98.6b98.4b97.6b100.0b94.5b95.8b89.7b

Accounts Payable

37.0m1.3b1.4b1.4b1.6b1.7b1.6b1.8b1.7b1.8b1.8b

Short-term debt

1.9b2.2b2.2b

Current Liabilities

37.0m7.7b8.1b8.1b7.9b9.6b12.7b15.1b10.5b10.9b9.1b

Long-term debt

33.7b33.7b33.7b30.1b29.0b25.9b26.0b25.9b25.9b23.7b

Total Debt

35.6b35.8b35.8b30.1b29.0b25.9b26.0b25.9b25.9b23.7b

Total Liabilities

37.0m51.8b52.7b51.9b47.7b48.1b48.1b49.5b42.9b45.5b39.4b

Additional Paid-in Capital

73.0k28.6b28.1b28.2b27.8b

Retained Earnings

(37.1m)54.2b53.7b53.8b52.8b52.5b52.3b24.0b25.4b23.4b24.7b

Total Equity

52.8b52.3b50.8b50.9b50.3b49.5b50.8b51.6b50.3b50.3b

Debt to Equity Ratio

0.7 x0.7 x0.7 x0.6 x0.6 x0.5 x0.5 x0.5 x0.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x

Financial Leverage

2 x2 x2 x1.9 x2 x2 x2 x1.8 x1.9 x1.8 x

Medtronic Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

3.1b2.7b3.5b4.0b3.1b

Depreciation and Amortization

349.0m1.3b2.8b2.0b2.6b

Accounts Receivable

(70.0m)(413.0m)(435.0m)(75.0m)(275.0m)

Inventories

(39.0m)(282.0m)(186.0m)(227.0m)(192.0m)

Accounts Payable

Cash From Operating Activities

5.0b3.4b5.2b6.9b4.7b

Purchases of PP&E

(396.0m)(1.0b)(1.3b)(1.1b)

Cash From Investing Activities

(3.6b)(17.1b)2.2b(1.6b)5.9b

Short-term Borrowings

(139.0m)(2.0m)(45.0m)

Long-term Borrowings

(565.0m)(1.3b)(5.1b)(863.0m)(7.4b)

Cash From Financing Activities

(918.0m)15.9b(9.5b)(3.3b)(12.0b)

Net Change in Cash

(2.0m)2.1b(1.3b)

Interest Paid

394.0m578.0m1.3b1.1b1.1b

Income Taxes Paid

521.0m632.0m1.4b1.0b2.5b

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q3, 2018Q1, 2019

Net Income

(37.1m)820.0m1.3b2.4b929.0m2.0b2.9b1.0b1.6b1.1b

Depreciation and Amortization

701.0m1.4b2.1b737.0m1.5b2.2b636.0m2.0b666.0m

Accounts Receivable

279.0m(1.0m)86.0m196.0m(89.0m)18.0m(88.0m)19.0m138.0m

Inventories

(207.0m)(326.0m)(388.0m)(101.0m)(187.0m)(261.0m)(318.0m)(180.0m)

Accounts Payable

1.3b1.4b1.4b13.0m85.0m

Cash From Operating Activities

816.0m2.1b3.9b1.6b3.0b5.1b737.0m3.6b1.7b

Cash From Investing Activities

(986.0m)(2.1b)(2.3b)(284.0m)(357.0m)(1.3b)83.0m5.7b643.0m

Long-term Borrowings

(1.0b)(1.6b)(1.6b)(17.0m)(252.0m)(361.0m)(8.0m)(4.2b)(12.0m)

Cash From Financing Activities

(1.7b)(2.5b)(3.7b)(1.2b)(2.7b)(4.0b)(1.1b)(8.1b)(1.6b)

Interest Paid

76.0m652.0m707.0m68.0m559.0m626.0m68.0m651.0m55.0m

Income Taxes Paid

636.0m1.0b1.2b115.0m258.0m474.0m417.0m911.0m348.0m

Medtronic Ratios

USDY, 2018

EV/EBIT

118.3 x

EV/CFO

85.9 x

Financial Leverage

1.8 x
Report incorrect company information

Medtronic Operating Metrics

Medtronic's Patients was reported to be 65 m in FY, 2016.
FY, 2014FY, 2015FY, 2016

Countries

160 160

Patents Issued

27 k53 k45 k

Patients

65 m
Report incorrect company information

Medtronic Human Capital

Medtronic's employees are reported to be approximately 49% female and 51% male.
FY, 2016FY, 2015FY, 2014
Male51 %52 %51 %
Female49 %48 %49 %
Report incorrect company information